Clal Insurance’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-23,000
| Closed | -$1.09M | – | 230 |
|
|
2025
Q3 | $1.09M | Hold |
23,000
| – | – | 0.01% | 101 |
|
|
2025
Q2 | $1.11M | Buy |
23,000
+5,000
| +28% | +$255K | 0.01% | 98 |
|
|
2025
Q1 | $998K | Sell |
18,000
-2,000
| -10% | -$108K | 0.01% | 96 |
|
|
2024
Q4 | $965K | Hold |
20,000
| – | – | 0.01% | 89 |
|
|
2024
Q3 | $1.15M | Sell |
20,000
-4,000
| -17% | -$216K | 0.01% | 92 |
|
|
2024
Q2 | $1.16M | Buy |
24,000
+4,000
| +20% | +$193K | 0.01% | 89 |
|
|
2024
Q1 | $972K | Hold |
20,000
| – | – | 0.01% | 105 |
|
|
2023
Q4 | $995K | Hold |
20,000
| – | – | 0.01% | 97 |
|
|
2023
Q3 | $1.07M | Hold |
20,000
| – | – | 0.02% | 96 |
|
|
2023
Q2 | $1.08M | Hold |
20,000
| – | – | 0.01% | 109 |
|
|
2023
Q1 | $1.09M | Buy |
+20,000
| New | +$973K | 0.02% | 113 |
|
|
2022
Q3 | – | Sell |
-22,000
| Closed | -$1.1M | – | 178 |
|
|
2022
Q2 | $1.1M | Hold |
22,000
| – | – | 0.01% | 133 |
|
|
2022
Q1 | $1.13M | Buy |
+22,000
| New | +$1.14M | 0.01% | 134 |
|
|
2021
Q4 | – | Sell |
-12,000
| Closed | -$579K | – | 242 |
|
|
2021
Q3 | $579K | Sell |
12,000
-3,500
| -23% | -$178K | 0.01% | 167 |
|
|
2021
Q2 | $816K | Sell |
15,500
-4,500
| -23% | -$235K | 0.01% | 159 |
|
|
2021
Q1 | $989K | Hold |
20,000
| – | – | 0.01% | 146 |
|
|
2020
Q4 | $908K | Sell |
20,000
-10,000
| -33% | -$493K | 0.01% | 108 |
|
|
2020
Q3 | $1.5M | Buy |
30,000
+9,250
| +45% | +$476K | 0.03% | 98 |
|
|
2020
Q2 | $1.06M | Buy |
+20,750
| New | +$1.01M | 0.02% | 99 |
|
Other funds holding SNY
MIP
